IP Library Granted Patent US 11,016,313
Granted Patent B2
US 11,016,313 · App. 16/214,483 · Granted May 25, 2021

Ophthalmic lens

Inventors: Prashant Santan (San Diego, CA); Newton M. Tarleton (Vista, CA)
Assignee: Signet Armorlite, Inc.
G02C7/107G02B1/10G02B1/11G02B5/283G02C7/10G02C7/104G02C7/105G02C7/108G02C2202/16
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,016,313
App. No.
16/214,483
Granted
May 25, 2021
Kind
B2
Abstract

A thin film coating for an ophthalmic lens is provided, that comprises alternating layers of high and low index materials. The coating attenuates the transmission of light and has a spectral reflectance curve characterized by a reflectance of at least about 90% in a range from 320 nm to 420 nm, by 50% at 440 nm, by 5% or less at 460 nm, and wherein the spectral reflectance curve is monotonically or strictly decreasing between 420 nm to 460 nm.

Claims (27)

1. An ophthalmic lens comprising:

an optical lens having a front surface and a back surface;

a coating on the front surface that attenuates transmission of light with a spectral reflectance curve that is monotonically decreasing from 90% or more to 10% or less, within the range from 420 nm to 460 nm.

2. The ophthalmic lens of claim 1 , wherein the spectral reflectance curve is strictly decreasing from 90% or more to 10% or less, within the range from 420 nm to 460 nm.

3. The ophthalmic lens of claim 1 , wherein the spectral reflectance curve at 50% reflectance within the range from 420 nm to 460 nm, has a slope m of between about −0.7 to about −0.62.

4. The ophthalmic lens of claim 1 , wherein the spectral reflectance curve at 440 nm has a slope m of between about −0.7 to about −0.62.

5. The ophthalmic lens of claim 1 , wherein the spectral reflectance curve is monotonically decreasing from 90% or more to 5% or less, within the range from 420 nm to 460 nm.

6. The ophthalmic lens of claim 1 , wherein the spectral reflectance curve is monotonically decreasing from 95% or more to 5% or less, within the range from 420 nm to 460 nm.

7. The ophthalmic lens of claim 1 , wherein the spectral reflectance curve is less than 20% from 460 nm to 700 nm.

8. The ophthalmic lens of claim 1 , wherein the spectral reflectance curve is less than 15% from 460 nm to 700 nm.

9. The ophthalmic lens of claim 1 , wherein the spectral reflectance curve further comprises a secondary peak of reflectance of at least 5%, within the range from 460 nm to 540 nm.

10. The ophthalmic lens of claim 9 , wherein the secondary peak of reflectance is at about 490 nm.

11. The ophthalmic lens of claim 9 , wherein the secondary peak of reflectance is between 5% to 15%.

12. The ophthalmic lens of claim 9 , wherein the secondary peak of reflectance has a full width half maximum of about 55 nm.

13. The ophthalmic lens of claim 9 , wherein the spectral reflectance curve is strictly decreasing from 90% or more to 10% or less, within the range from 420 nm to 460 nm.

14. The ophthalmic lens of claim 9 , wherein the spectral reflectance curve at 50% reflectance between 400 nm to 450 nm has a slope m of between about −0.7 to about −0.62.

15. The ophthalmic lens of claim 9 , wherein the spectral reflectance curve at 440 nm has a slope m of between about −0.7 to about −0.62.

16. The ophthalmic lens of claim 9 , wherein the spectral reflectance curve is monotonically decreasing from 90% or more to 5% or less, within the range from 420 nm to 460 nm.

17. The ophthalmic lens of claim 9 , wherein the spectral reflectance curve is monotonically decreasing from 95% or more to 5% or less, within the range from 420 nm to 460 nm.

18. An ophthalmic lens comprising:

an optical lens having a front surface and a back surface;

a coating on the front surface that attenuates transmission of light with a spectral reflectance curve that is monotonically decreasing from 80% or more to 10% or less, within the range from 420 nm to 460 nm.

19. The ophthalmic lens of claim 18 , wherein the spectral reflectance curve is strictly decreasing from 80% or more to 10% or less, within the range from 420 nm to 460 nm.

20. The ophthalmic lens of claim 18 , wherein the spectral reflectance curve further comprises a secondary peak of reflectance of at least 5%, within the range from 460 nm to 540 nm.

21. The ophthalmic lens of claim 20 , wherein the secondary peak of reflectance is between 5% to 15%.

22. The ophthalmic lens of claim 21 , wherein the secondary peak of reflectance has a full width half maximum of about 55 nm.

23. The ophthalmic lens of claim 20 , wherein the secondary peak of reflectance is at about 490 nm.

Assignments (1)
MERGER Recorded Apr 3, 2023
From: SIGNET ARMORLITE, INC.
To: ESSILOR LABORATORIES OF AMERICA, INC.
Reel/Frame 063207/0920 →
Continuity (2)
Continuation 14985011 · Dec 30, 2015
Related Publication 20190107737A1 · Apr 11, 2019